本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Protagonist Therapeutics Inc

143.70
+0.86000.60%
盤後143.700.00000.00%19:30 EDT
成交量:55.89萬
成交額:8,045.49萬
市值:92.99億
市盈率:139.51
高:146.50
開:144.39
低:142.31
收:142.84
52周最高:160.81
52周最低:58.91
股本:6,470.83萬
流通股本:6,316.60萬
量比:1.01
換手率:0.88%
股息:- -
股息率:- -
每股收益(TTM):1.03
每股收益(LYR):-2.0500
淨資產收益率:10.98%
總資產收益率:4.55%
市淨率:11.05
市盈率(LYR):-70.10

資料載入中...

2026/05/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/12

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/05

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/05

重要事件披露

Form 8-K - Current report
2026/04/30

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/29

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/25

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/25

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/25

重要事件披露

Form 8-K - Current report
2026/02/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/02/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities